4//SEC Filing
Meredith Ian T 4
Accession 0001225208-22-003295
CIK 0000885725other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:21 PM ET
Size
6.0 KB
Accession
0001225208-22-003295
Insider Transaction Report
Form 4
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
- Award
Performance Share Units
2022-02-22+6,540→ 6,540 totalFrom: 2023-12-31Exp: 2023-12-31→ Common Stock (6,540 underlying)
Footnotes (2)
- [F1]Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001693920
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:21 PM ET
- Size
- 6.0 KB